NEWS
Incorporated “NOVIUS Company,” a local subsidiary in Delaware, U.S.A.
(Head office: Hachioji City, Tokyo; Representative Director: Tomoko Fujino), which is engaged in the further s
Top 10 Finalists 「DWEN Dream Tech Contest」
Our company was selected as a finalist in the Dell Women Entrepreneur Business Contest 2023, a business contes
We’re able to obtain an Unique Entity Identifier.
On May 16, 2023, we have obtained a Unique Entity Identifier (UEI), which allows us to receive grants and assi
We’re able to obtain an NCAGE CODE number.
We are pleased to announce that we have obtained the NCAGE code “JB211” as of April 18, 2023. The
We started AGI (Artificial General Intelligence) development this year
We are pleased to announce that we will begin developing/providing AGI (Artificial General Intelligence) this
we Selected as one of the 10 finalists for the 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC
The 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC we Selected as one
Incorporated “NOVIUS Company,” a local subsidiary in Delaware, U.S.A.
(Head office: Hachioji City, Tokyo; Representative Director: Tomoko Fujino), which is engaged in the further spread of real-time 2D to 3D technology that creates stereoscopic images using AI to generate medical-related images using artificial intelligence technology in the field of digital health, as well as joint research and development with the National Cancer Center Hospital, (Head Office: Hachioji City, Tokyo; President: Tomoko Fujino), which is also engaged in joint research and development with the National Cancer Center Central Hospital, announces that it has established a local subsidiary, “NOVIUS Company, Ltd.
Top 10 Finalists 「DWEN Dream Tech Contest」
Our company was selected as a finalist in the Dell Women Entrepreneur Business Contest 2023, a business contest sponsored by Dell Technologies, Inc. that aims to discover and support outstanding women entrepreneurs who are adopting technology as a growth strategy.
We’re able to obtain an Unique Entity Identifier.
On May 16, 2023, we have obtained a Unique Entity Identifier (UEI), which allows us to receive grants and assistance from the U.S. federal government.
We will gradually apply to various national agencies, including U.S. grants.
We’re able to obtain an NCAGE CODE number.
We are pleased to announce that we have obtained the NCAGE code “JB211” as of April 18, 2023.
The NGAGE code is a five-digit code (a combination of letters and numbers) used in transactions with NATO countries, the U.S. federal government, and U.S. military agencies. The acquisition of this code will enable us to conduct sales activities through reliable channels with NATO countries, the U.S. federal government, and U.S. military agencies, as well as direct sales activities to the U.S. government and other entities.
We started AGI (Artificial General Intelligence) development this year
We are pleased to announce that we will begin developing/providing AGI (Artificial General Intelligence) this year. The development has already started and will be provided on a contract basis from the end of this month, April. In the past, we have developed what is called specialized AI (AI that can detect something or respond only to a certain field) on a contract basis or with our own technology. AGI is the next-generation AI of today. We have been researching the introduction of embedded AI in our own technology for a long time.
From this fiscal year, we would like to focus on the development of generative AI, as represented by AGI. AI has surpassed the “creative domain” that humans were said to be uniquely capable of, and at the same time, it has shown us wonderful possibilities.
We believe that AI/AGI is still an unknown world with various possibilities and hopes. No one knows for sure how AI will change the future, just as the Industrial Revolution changed the future.
This is because we are the “First Generation” of AI.
Specifically, we will begin to develop AGI with human sensibilities and thinking ability.
There are multiple possibilities, and even fears, about what could happen with the advancement of AGI. For example, one researcher has said that we may come to have servants.
By 2025, he predicts that robots will be
AGI robots will be able to do human jobs more efficiently.
AGI robots will be able to do human jobs more efficiently. In addition, there are other possible impacts of this technology.
We will continue to develop and provide AI and AGI according to our mission.
we Selected as one of the 10 finalists for the 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC
The 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC
we Selected as one of the 10 finalists
About The 31st General Assembly of the Japanese Association of Medical Sciences Exposition
The theme of the 31st Annual Meeting, to be held in 2023, is “Big Data Opens the Way to the Future of Medicine and Medical Care: In Search of a Prosperous 100-year Life Era. In light of the post-coronary and super-aging society with a declining birthrate, we hope to provide an opportunity for many medical professionals to learn about the latest in medicine and medical care, as well as to look at the overall picture and think about medical care for a prosperous 100-year life age through academic conferences and academic exhibitions. The “Annual Meeting of the Medical Society of Japan Exposition” will be held in the same area during the period of the “Annual Meeting of the Medical Society of Japan” as a festival of “health and medicine” where more people can learn and experience the latest information on health and medicine.
